Envestnet Asset Management Inc. Has $11.37 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Envestnet Asset Management Inc. raised its position in HealthEquity, Inc. (NASDAQ:HQY) by 12.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 128,657 shares of the company’s stock after purchasing an additional 13,918 shares during the period. Envestnet Asset Management Inc. owned 0.15% of HealthEquity worth $11,369,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HQY. Versant Capital Management Inc bought a new stake in shares of HealthEquity in the 1st quarter worth $28,000. Transce3nd LLC bought a new stake in shares of HealthEquity in the 4th quarter worth $29,000. Proficio Capital Partners LLC bought a new stake in shares of HealthEquity in the 4th quarter worth $39,000. Whipplewood Advisors LLC grew its stake in shares of HealthEquity by 5,060.0% in the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company’s stock worth $68,000 after acquiring an additional 759 shares in the last quarter. Finally, Huntington National Bank grew its stake in shares of HealthEquity by 89.4% in the 4th quarter. Huntington National Bank now owns 767 shares of the company’s stock worth $74,000 after acquiring an additional 362 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY stock opened at $97.70 on Friday. The company has a market cap of $8.45 billion, a price-to-earnings ratio of 71.31, a price-to-earnings-growth ratio of 1.51 and a beta of 0.49. The stock has a 50 day simple moving average of $101.65 and a 200-day simple moving average of $98.48. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same quarter last year, the business posted $0.80 earnings per share. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Elimelech Rosner sold 58,000 shares of the business’s stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares of the company’s stock, valued at approximately $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

HQY has been the topic of several recent research reports. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Friday, June 6th. The Goldman Sachs Group upped their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the company a “neutral” rating in a report on Wednesday, June 4th. Bank of America increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. JMP Securities increased their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a “market outperform” rating in a report on Wednesday, June 4th. Finally, KeyCorp lowered their price target on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and an average target price of $118.55.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.